It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Globus Medical, Inc.’s GMED growth in the third quarter can be attributed to the robust prospect in the musculoskeletal space. The company’s merger with NuVasive is expected to generate ...

But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks ...

The most recent guidance for Globus Medical (GMED) was reported on January 8, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $3.40 to $3.50 ...

Short interest in Globus Medical Inc (NYSE:GMED) decreased during the last reporting period, falling from 2.79M to 2.44M. This put 2.4% of the company's publicly available shares short.

But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a Zacks Rank #3 (Hold) stock, with a Growth Style Score of A and VGM Score of A. Earnings are ...